---
figid: PMC10527326__cancers-15-04566-g002
figtitle: The Biomarkers, Molecular Targets and Mechanisms of Non-Alcoholic Steatohepatitis-Driven
  Hepatocarcinogenesis
organisms:
- NA
organisms_ner:
- Drosophila melanogaster
- Homo sapiens
pmcid: PMC10527326
filename: cancers-15-04566-g002.jpg
figlink: /pmc/articles/PMC10527326/figure/cancers-15-04566-f002/
number: F2
caption: 'Metabolic and signaling pathways in NAFLD/NASH-associated HCC. Abnormal
  metabolism: accumulation of arginine, glucose metabolites, phosphocreatine, SAM,
  GSH, and alterations of urea and NO cycles are observed in NAFLD/NASH HCC. These
  events are associated with developed lipotoxicity, activation of de novo lipogenesis
  (SREBP-1), lipid peroxidation, fatty acid β oxidation, mitochondrial dysfunction,
  activation of oxidative (MAPK, Nrf2, NF-kB, C-jun/C-fos/C-myc/AP1) and ER stresses
  (p62, Keap1, Nrf2, STING, CNPY2)-related signaling, wnt/β-catenin pathway, and suppression
  of autophagy (mTORC1, AMPK, p62), with the central role for mTOR pathway. Abbreviations:
  ROS, reactive oxygen species; NO, nitric oxide; ER, endoplasmic reticulum; TCA,
  tricarboxylic acid cycle; INSR, insulin receptor; GLUT1, glucose trasporter 1; STING1,
  stimulator of interferon response cGAMP interactor 1; SAM, S-adeninemethyonine;
  SAH, S-adenosyl-L-homocysteine; Ub, ubiquitin; LC3, microtubule-associated protein
  1A/1B−light chain 3; sMAF, small maf protein; CAT, cationic amino acid transporter;
  PKC, protein kinase C; MnSOD, manganese superoxide dismutase; PIP2, phosphatidylinositol
  4,5-bisphosphate; PIP3, phosphatidylinositol 3,4,5-triphosphate; PI3K, phosphoinositide
  3-kinase; AKT, protein kinase B (serine/threonine-specific protein kinase); p38,
  p38 mitogen-activated protein kinase; MEK, mitogen-activated protein kinase kinase;
  ERK, extracellular signal-regulated kinase; JNK, c-Jun N-terminal kinase; ARG1,
  arginase1; ASL, argininosuccinate lyase; ASS, argininosuccinate synthase; AGAT,
  arginine-glycine amidinotransferase; GAMT, guanidinoacetate N-methyltransferase;
  NOS, nitric oxide synthase; CK, creatine kinase; HK, hexokinase; G6PI, glucose-6-phosphate
  isomerase; PFKM, 6-phosphofructokinase; G6PC, glucose-6-phosphatase; FBP, fructose
  1,6-bisphosphate aldolase; PGM, phosphoglycerate mutase; MAT, methionine adenosyltransferase;
  GPX, glutathione peroxidase, GR, glutathione reductase.'
papertitle: Recent Insights into the Biomarkers, Molecular Targets and Mechanisms
  of Non-Alcoholic Steatohepatitis-Driven Hepatocarcinogenesis.
reftext: Anna Kakehashi, et al. Cancers (Basel). 2023 Sep;15(18):4566.
year: '2023'
doi: 10.3390/cancers15184566
journal_title: Cancers
journal_nlm_ta: Cancers (Basel)
publisher_name: MDPI
keywords: NAFLD | NASH | HCC | biomarker | hepatocarcinogenesis mechanisms
automl_pathway: 0.8777416
figid_alias: PMC10527326__F2
figtype: Figure
redirect_from: /figures/PMC10527326__F2
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC10527326__cancers-15-04566-g002.html
  '@type': Dataset
  description: 'Metabolic and signaling pathways in NAFLD/NASH-associated HCC. Abnormal
    metabolism: accumulation of arginine, glucose metabolites, phosphocreatine, SAM,
    GSH, and alterations of urea and NO cycles are observed in NAFLD/NASH HCC. These
    events are associated with developed lipotoxicity, activation of de novo lipogenesis
    (SREBP-1), lipid peroxidation, fatty acid β oxidation, mitochondrial dysfunction,
    activation of oxidative (MAPK, Nrf2, NF-kB, C-jun/C-fos/C-myc/AP1) and ER stresses
    (p62, Keap1, Nrf2, STING, CNPY2)-related signaling, wnt/β-catenin pathway, and
    suppression of autophagy (mTORC1, AMPK, p62), with the central role for mTOR pathway.
    Abbreviations: ROS, reactive oxygen species; NO, nitric oxide; ER, endoplasmic
    reticulum; TCA, tricarboxylic acid cycle; INSR, insulin receptor; GLUT1, glucose
    trasporter 1; STING1, stimulator of interferon response cGAMP interactor 1; SAM,
    S-adeninemethyonine; SAH, S-adenosyl-L-homocysteine; Ub, ubiquitin; LC3, microtubule-associated
    protein 1A/1B−light chain 3; sMAF, small maf protein; CAT, cationic amino acid
    transporter; PKC, protein kinase C; MnSOD, manganese superoxide dismutase; PIP2,
    phosphatidylinositol 4,5-bisphosphate; PIP3, phosphatidylinositol 3,4,5-triphosphate;
    PI3K, phosphoinositide 3-kinase; AKT, protein kinase B (serine/threonine-specific
    protein kinase); p38, p38 mitogen-activated protein kinase; MEK, mitogen-activated
    protein kinase kinase; ERK, extracellular signal-regulated kinase; JNK, c-Jun
    N-terminal kinase; ARG1, arginase1; ASL, argininosuccinate lyase; ASS, argininosuccinate
    synthase; AGAT, arginine-glycine amidinotransferase; GAMT, guanidinoacetate N-methyltransferase;
    NOS, nitric oxide synthase; CK, creatine kinase; HK, hexokinase; G6PI, glucose-6-phosphate
    isomerase; PFKM, 6-phosphofructokinase; G6PC, glucose-6-phosphatase; FBP, fructose
    1,6-bisphosphate aldolase; PGM, phosphoglycerate mutase; MAT, methionine adenosyltransferase;
    GPX, glutathione peroxidase, GR, glutathione reductase.'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - de
  - ref(2)P
  - DCTN4-p62
  - Tfb1
  - Nup62
  - Taf6
  - how
  - Keap1
  - cnc
  - lic
  - p38b
  - Nurf-38
  - Ebp
  - AIMP2
  - p38a
  - Hrb87F
  - p38c
  - Dif
  - dl
  - Rel
  - ras
  - Ras64B
  - Ras85D
  - inaC
  - Pkc98E
  - aPKC
  - Pkc53E
  - Pi3K21B
  - Pi3K59F
  - Pi3K68D
  - Pi3K92E
  - Raf
  - Dsor1
  - bsk
  - rl
  - syndrome
  - foxo
  - SNF4Agamma
  - AMPKalpha
  - Cat
  - Ca-alpha1T
  - ChAT
  - sv
  - CycE
  - cyc
  - CkIIbeta
  - Andorra
  - Anp
  - Acam
  - Jra
  - kay
  - Myc
  - AP-1gamma
  - fz
  - Akt
  - Nos
  - nos
  - Crtc
  - ATPsynbeta
  - Atpalpha
  - Mtor
  - Tor
  - Sod2
  - mat
  - Mad
  - sam
  - qkr54B
  - sls
  - Sam-S
  - gr
  - PHGPx
  - Atg8a
  - arm
  - so
  - CNPY2
  - STING1
  - GTF2H1
  - SQSTM1
  - KHDRBS1
  - NUP62
  - DCTN4
  - KEAP1
  - GABPA
  - NFE2L2
  - CRK
  - MAPK14
  - MAPK1
  - GRAP2
  - AHSA1
  - POLDIP2
  - MAPK11
  - MAPK12
  - MAPK13
  - NFKB1
  - KRAS
  - HRAS
  - NRAS
  - PRRT2
  - PRKCA
  - PRKCB
  - PRKCD
  - PRKCE
  - PRKCG
  - PRKCH
  - PRKCI
  - PRKCQ
  - PRKCZ
  - PRKD3
  - IRS1
  - PIK3CA
  - PIK3CB
  - PIK3CD
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3R5
  - PIK3R6
  - PIK3R1
  - PIK3R2
  - NRIP1
  - ZHX2
  - ARAF
  - BRAF
  - RAF1
  - MAP2K1
  - MAP2K2
  - MAPK8
  - MAPK9
  - MAPK10
  - MAPK3
  - FOXO1
  - FOXO3
  - FOXO4
  - FOXO6
  - PRKAA1
  - PRKAA2
  - PRKAB1
  - PRKAB2
  - PRKAG1
  - PRKAG2
  - PRKAG3
  - CAT
  - CRAT
  - GLYAT
  - JUN
  - FOS
  - MYC
  - FOSB
  - JUNB
  - JUND
  - FOSL1
  - FOSL2
  - FZD1
  - FZD10
  - FZD2
  - FZD3
  - FZD4
  - FZD5
  - FZD6
  - FZD7
  - FZD8
  - FZD9
  - GAMT
  - AKT1
  - AKT2
  - AKT3
  - NOS1
  - NOS2
  - NOS3
  - MTOR
  - RPTOR
  - ATP8A2
  - SOD2
  - ACAT1
  - MAT1A
  - GPX1
  - GPX2
  - GPX3
  - GPX4
  - GPX5
  - GPX6
  - GPX7
  - GPX8
  - MAP1LC3A
  - CTNNB1
  - cholesterol
  - Triacylglycerol
  - Arginine
  - Ornithine
  - Glycine
  - Argininosuccinate
  - Guanidinoacetate
  - Creatine
  - Phosphocreatinef Glucose-6-P-Glucose-1-P
  - Creatinine
  - ATP
  - Fructose
  - Glucose
  - fatty acids
  - Fructose-6-P
  - Lactate
  - Fatty acid
  - Methionine
  - Cystathionine
  - Cysteine
  - GSH
  - GSSG
  - TCA
  - Metabolic syndrome
  - Phosphocreatinef Glucose-6-P-Glucose-1-P
  - MAT
---
